期刊
SCIENCE ADVANCES
卷 7, 期 35, 页码 -出版社
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/sciadv.abe3600
关键词
-
资金
- National Natural Science Foundation of China [81870839, 82071218, 81630026, 81930029]
- Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Neuroscience Center
- China Human Brain Banking Consortium
This study showed that increased expression of Calhm2 in an AD mouse model, and its knockout significantly reduced amyloid beta deposition, neuroinflammation, and cognitive impairments. Knockout of Calhm2 inhibited microglial proinflammatory activity but increased phagocytic activity, leading to the restoration of the balance between inflammation and phagocytosis.
Alzheimer's disease (AD) is the most common neurodegenerative disease in the world. Neuronal calcium dysfunction and microglial-mediated neuroinflammation are closely associated with the development of AD. However, it remains unknown whether calcium dysfunction contributes to microglial activation and, in turn, AD pathology in vivo. In this study, we demonstrated that the expression of calcium homeostasis modulator family protein 2 (Calhm2) is increased in an AD mouse model. In 5xFAD mice carrying five familial AD gene mutations, both conventional knockout of Calhm2 and conditional microglial knockout of Calhm2 significantly reduced amyloid beta deposition, neuroinflammation, and cognitive impairments. Mechanistically, knockout of Calhm2 inhibited microglial proinflammatory activity but increased phagocytic activity, leading to restoration of the balance between inflammation and phagocytosis. In addition, knockout of Calhm2 reduced acute LPS-induced neuroinflammation. These results highlight an important role for Calhm2 in microglial activation and provide a potential therapeutic target for diseases related to microglia-mediated neuroinflammation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据